ADR Program for Foreign Investors
Hypera Pharma implemented its Level I ADR (American Depositary Receipt) program on May 26, 2010, aiming to expand the access to investors, especially those based outside Brazil, as well as to increase the liquidity of its shares.
Hypera Pharma ADRs are traded under the ticker HYPMY and counts on J.P. Morgan Chase Bank, N.A. as depositary bank and on Banco Bradesco S.A. as custodian institution.
| Hypera Pharma ADR details: | |
|---|---|
| Ticker: | HYPMY |
| Stock Exchange: | American Over-the-counter (OTC) Market |
| Ratio: | 1 ADR corresponds to 1 common share |
| CUSIP: | 44914U106 |
| DR ISIN: | US44914U1060 |
| Website: | Depositary Receipts – J.P. Morgan Markets |
For holders of ADRs registered in the depositary bank, please contact:
Banco Bradesco S.A.
Address: Núcleo Cidade de Deus – Prédio Amarelo, 06029-900 – Osasco – SP
E-mail: bcsf.escrituracao@bradesco.com.br
Phone: +55 11 3684-9441
Last updated on June 17, 2025.